Keeping pace with the evolving global landscape in vaccine development

<!DOCTYPE html> <html lang="en"> <head> <title>Keeping pace with the evolving global landscape in vaccine development - Endpoints Webinars</title> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta http-equiv="content-type" content="text/html; charset=utf-8"> <meta name="viewport" content="width=device-width, user-scalable=no"> <link rel="apple-touch-icon" sizes="180x180" href="/assets/images/favicon/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="/assets/images/favicon/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="/assets/images/favicon/favicon-16x16.png"> <link rel="manifest" href="/assets/images/favicon/site.webmanifest"> <link rel="mask-icon" href="/assets/images/favicon/safari-pinned-tab.svg" color="#5bbad5"> <link rel="shortcut icon" href="/assets/images/favicon/favicon.ico"> <meta name="msapplication-TileColor" content="#da532c"> <meta name="msapplication-config" content="/assets/images/favicon/browserconfig.xml"> <meta name="theme-color" content="#ffffff"> <meta property="og:description" content="Hear from a panel of Life Science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space. What has been COVID-19’s impact on drug development and the regulatory landscape? Key factors contributing to Asia Pacific being recognised as the hub for vaccine development" /> <meta property="og:title" content="Keeping pace with the evolving global landscape in vaccine development - Endpoints Webinars" /> <meta property="og:url" content="https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/" /> <meta property="og:site_name" content="Endpoints Webinars" /> <meta property="og:type" content="article" /> <meta property="article:section" content="Business & Health" /> <meta name="twitter:site" content="@endpts"> <link rel="canonical" href="https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/" /> <meta property="og:image" content="https://webinars.endpts.com/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/social_preview.jpg" /> <meta property="twitter:image" content="https://webinars.endpts.com/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/social_preview.jpg" /> <meta name="twitter:card" content="summary_large_image"><link href="https://webinars.endpts.com/assets/css/bootstrap.min.css" rel="stylesheet" type="text/css"> <link href="https://webinars.endpts.com/assets/css/style.css?v=1.0.17" rel="stylesheet" type="text/css"> <link href="https://webinars.endpts.com/assets/css/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development.css?v=1.0.17" rel="stylesheet" type="text/css"> <script async src="https://www.googletagmanager.com/gtag/js?id=G-ZS375P62LY"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-ZS375P62LY'); gtag('config', 'AW-370093343'); </script> </head> <body id="page-keeping-pace-with-the-evolving-global-landscape-in-vaccine-development"> <header class="header_area"> <div class="main_menu"> <nav class="navbar navbar-expand-lg navbar-light"> <div class="container navi-border"> <a href="/" title="Endpoints Webinars"> <div class="navbar-brand logo_h"> <svg version="1.1" width="280px" class="d-inline-block align-top ew-logo" alt="Endpoints Webinars" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewbox="0 0 280 46" style="enable-background:new 0 0 280 46;" xml:space="preserve"> <path class="ew-logo-primary" d="M84.3,0.2l-7.7,24.1h-0.5l-8-24.1h-7.8l-7.3,24.1h-0.5L44.3,0.2h-4h-8.8H0V46h39l-3.9-10.2h-24v-8.1h20.6 L28.1,18h-17v-7.6h24.3L48.7,46h7.7l8-25.6h0.4L72.2,46h7.7L97.1,0.2H84.3z"></path> <path class="ew-logo-secondary" d="M122.2,33.3l-4.5,12.5h-1l-7-17.7l2.5-0.5l4.9,12.8h0.2l4.5-12.8h0.6l4.7,12.8h0.2l4.8-12.8l2.5,0.5l-7,17.7h-1 L122.2,33.3C122.4,33.3,122.2,33.3,122.2,33.3z M151.2,30.1H142v5.3h8.1v2.3H142v5.7h9.5v2.3h-12.1V27.8h11.7L151.2,30.1L151.2,30.1 z M166.8,36.5c2.2,0.4,3.7,2.1,3.7,4.2c0,3.1-2.4,4.9-6.3,4.9h-6.4V27.8h5.9c4.2,0,5.8,2.4,5.8,4.7c0,1.6-0.8,3.1-2.6,3.8V36.5 L166.8,36.5z M163.7,30.1h-3.5v5.3h3.6c1.9,0,2.9-0.9,2.9-2.7C166.7,30.7,165.3,30.1,163.7,30.1z M160.2,37.7v5.7h4.2 c1.9,0,3.4-0.9,3.4-2.8s-1.6-2.9-3.6-2.9L160.2,37.7L160.2,37.7z M179.1,45.6h-2.5V27.8h2.5V45.6z M199.9,40.7l0.3-0.1V27.8h2.5 v17.8l-1,0.3l-12.3-13l-0.3,0.1v12.7h-2.5V27.9l1-0.3L199.9,40.7z M220.1,41.5h-8.2l-1.9,4.3l-2.6-0.4l8.3-17.8h0.5l8.4,17.8 l-2.6,0.4L220.1,41.5z M212.9,39.2h6.1l-3-6.6h-0.1L212.9,39.2z M243.5,45v0.4l-2.4,0.5l-6.3-7.2h-2.9v7h-2.5V27.8h6.5 c3.7,0,6.1,2.2,6.1,5.3c0,2.7-1.6,4.7-4.4,5.2L243.5,45z M235.8,30.1h-3.8v6.3h3.8c2.3,0,3.7-1.1,3.7-3.3 C239.5,31.1,237.9,30.1,235.8,30.1z M248.5,41.7c1.5,1.2,3.2,1.9,5.6,1.9c3.1,0,4.2-1.3,4.2-2.7c0-1.6-1.5-2.3-4.5-3.6 c-4.1-1.8-5.5-2.9-5.5-5.2s2.1-4.7,6.1-4.7c2.7,0,4.9,0.9,6,1.9l-0.9,2.1c-1.5-1.1-3.2-1.6-5.1-1.6c-2.3,0-3.7,1-3.7,2.2 c0,1.3,1.1,1.9,4.7,3.4c4.1,1.6,5.4,3.3,5.4,5.7c0,3-2.6,4.9-6.9,4.9c-2.9,0-5.5-1.1-6.5-2.1L248.5,41.7z M122.8,4.6h-8.1v3h7.1v3.8 h-7.1v3.2h8.4v4H110V0.6h12.8L122.8,4.6L122.8,4.6z M141.2,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L141.2,10.9z M151.7,18.7V0.6h6.4c5.4,0,9.5,3.7,9.5,9.1c0,5.8-4,9.1-9.5,9.1C158.1,18.7,151.7,18.7,151.7,18.7z M158.4,14.7 c2.6,0,4.4-1.8,4.4-5.1c0-3.1-2.5-4.9-4.5-4.9h-2.1v10.1C156.2,14.7,158.4,14.7,158.4,14.7z M178.9,12.5H177v6.2h-4.7V0.6h6.7 c4.1,0,7,2.4,7,6.3C186,9.3,184.3,12.5,178.9,12.5z M178.5,4.4H177v4.5h1.6c1.5,0,2.5-0.7,2.5-2.1C181.1,5.5,180,4.4,178.5,4.4z M199.3,19.1c-5.7,0-9.7-4.1-9.7-9.3c0-5.8,4.7-9.5,9.7-9.5c4.9,0,9.7,3.7,9.7,9.5C208.9,14.9,205.1,19.1,199.3,19.1z M199.2,4.4 c-2.5,0-4.9,1.9-4.9,5.3c0,2.7,1.6,5.3,4.9,5.3c2.7,0,4.9-2,4.9-5.3C204.1,6.5,201.9,4.4,199.2,4.4z M218.6,18.7h-4.7V0.6h4.7V18.7z M237.3,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L237.3,10.9z M257,4.6v14.1h-4.7V4.6h-5.5v-4h15.6v4H257L257,4.6z M267.1,13.2c1.6,1,3.7,1.9,5.8,1.9c1.6,0,2.4-0.7,2.4-1.5c0-1.1-1.2-1.5-3.5-2.6c-3.7-1.7-5.2-3-5.2-5.7s2.2-5.2,6.7-5.2 c2.6,0,4.8,0.6,6.4,1.7l-1.2,3.8c-1.8-1-3.6-1.6-5.3-1.6c-1.4,0-2,0.5-2,1.3s0.7,1.2,3.6,2.5c3.9,1.8,5.3,3.5,5.3,5.9 c0,3.4-3.1,5.2-7.4,5.2c-3.1,0-5.8-1.1-6.9-2.1L267.1,13.2z"></path> </svg> </div> </a> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation"> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> <div class="collapse navbar-collapse offset" id="navbarSupportedContent"> <ul class="nav navbar-nav menu_nav justify-content-end"> <li class="nav-item"> <a class="nav-link" href="https://endpts.com" target="_blank" title="Endpoints News">Endpoints News</a> </li> <li class="reg-button" data-block-name="register">watch now</li> </ul> </div> </div> </nav> </div> </header> <section id="hero-section"> <div class="container"> <div class="row d-flex no-gutters date-time"> <div class="on-demand">WEBINAR RECORDING AVAILABLE - WATCH ON DEMAND</div> </div> <div class="hero-content"> <h1>Keeping pace with the evolving global landscape in vaccine development </h1> <div class="abstract"> <p>Hear from a panel of Life Science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space. What has been COVID-19’s impact on drug development and the regulatory landscape? Key factors contributing to Asia Pacific being recognised as the hub for vaccine development and opportunities for biotech’s to leverage. Key considerations for pre-clinical and clinical planning to accelerate vaccine development, supporting a robust global strategy. </p> </div>  <div class="col-md-12 align-self-center sponsor-part">SPONSORED BY <a href="https://novotech-cro.com/" target="_blank" rel="noopener nofollow"><img src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/sponsor-logo.png"></a> </div> </div> </div> <div class="fixed-bottom cta-fixed"> <div class="container"> <div class="row d-flex"> <div class="col-md-3 align-self-center social order-3 order-md-1">SHARE ON <a href="https://www.linkedin.com/shareArticle?mini=true&source=https%3A%2F%2Fwebinars.endpts.com%2F&title=Endpoints+Webinars%3A+Keeping+pace+with+the+evolving+global+landscape+in+vaccine+development+&url=https%3A%2F%2Fwebinars.endpts.com%2Fkeeping-pace-with-the-evolving-global-landscape-in-vaccine-development" target="_blank" rel="noopener nofollow"><img src="/assets/images/social/social-linkedin.svg"></a> <a href="https://twitter.com/intent/tweet?text=Endpoints+Webinars%3A+Keeping+pace+with+the+evolving+global+landscape+in+vaccine+development++https%3A%2F%2Fwebinars.endpts.com%2Fkeeping-pace-with-the-evolving-global-landscape-in-vaccine-development" target="_blank" rel="noopener nofollow"><img src="/assets/images/social/social-twitter.svg"></a> </div> <div class="col-md-5 order-1"> </div> <div class="col-md-4 align-self-center order-2"> <div class="reg-button" data-block-name="register">watch now</div> </vodiv> </div> </div> </div> </section><section class="pt-5 register-section" id="register"> <div class="container register-states pt-4"> <div class="section-title mb-0">Watch the webinar on demand</div> <div class="col-md-4 m-auto"> <a class="reg-button" href="https://vimeo.com/806365419/1c3cd466ad" target="_blank" rel="noopener nofollow">watch now</a> </div> </div> </section> <section class="speakers-section"> <div class="container"> <div class="row speaker-row align-items-top"> <div class="col-lg-3 col-sm-4 mb-lg-0 mb-4"> <img class="card-img rounded-circle" src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/panelists/SushantSahastrabuddhe.jpg" alt="Sushant Sahastrabuddhe" /> </div>  <div class="col-lg-9 col-sm-8 speaker-info"> <h3>Sushant Sahastrabuddhe</h3> <h5>Associate Director General, International Vaccine Institute (IVI)</h5> <p>Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), joined in July 2010, leading the clinical trials of IVI’s typhoid vaccine and process to achieve its licensure, the global clinical development of and licensure of SK bioscience’s COVID-19 vaccines and Phase 1 and 2 trials of Bharat Biotech’s Chikungunya vaccine. As a vaccine enthusiast with more than 17 years of experience in multiple countries across diverse projects, he continues to lead collaborative efforts with companies and partners in Korea, India and globally to get these vaccines through early- to late-stages of their clinical development. Dr. Sahastrabuddhe is also the Associate Editor for Vaccines for tropical diseases and associated with Yonsei University as Research Professor and with Universite Claude Bernanrd, Lyon France as Research Fellow. In 2021, Dr. Sahastrabuddhe was named an ‘Honorary Citizen of Seoul’ for his contributions to the joint efforts with Korean companies and international partners to develop vaccines against COVID-19 and other diseases.</p> </div>  </div>  <div class="row speaker-row align-items-top"> <div class="col-lg-3 col-sm-4 mb-lg-0 mb-4"> <img class="card-img rounded-circle" src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/panelists/PaulGriffin.jpg" alt="Paul Griffin" /> </div>  <div class="col-lg-9 col-sm-8 speaker-info"> <h3>Paul Griffin</h3> <h5>Associate Professor, Infectious Diseases Physician, Microbiologist, University of Queensland</h5> <p>An Infectious Diseases Physician and Microbiologist, Dr. Paul Griffin was appointed as the Director of Infectious Diseases at Mater Health Services in 2013 and continues an appointment as an Associate Professor of Medicine at the University of Queensland Medical School. Additionally, Dr. Griffin chairs the Advanced Training Committee in Infectious Diseases with the Royal Australasian College of Physicians, the committee that oversees the training of Infectious Diseases specialists in Australia. Previously, Dr. Griffin was the Principal Investigator (PI) and Medical Director at Nucleus Network, a contract research organization specializing in infectious diseases trials, which included a PI role on in excess of 125 clinical trials predominantly in Infectious Diseases including novel vaccines and COVID-19 vaccines. With fellowships in Infectious Diseases from the Royal Australasian College of Physicians, in Clinical Microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine, Dr. Griffin has an active interest in vaccine education and advocacy and has become a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.</p> </div>  </div>  <div class="row speaker-row align-items-top"> <div class="col-lg-3 col-sm-4 mb-lg-0 mb-4"> <img class="card-img rounded-circle" src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/panelists/JenniferArellano.jpg" alt="Jennifer Arellano" /> </div>  <div class="col-lg-9 col-sm-8 speaker-info"> <h3>Jennifer Arellano</h3> <h5>Director of Clinical Services (Philippines), Novotech</h5> <p>Jennifer Arellano is the Director of Clinical Services in the Philippines with over 25 years of technical and leadership experience in managing clinical trial operations for sponsors and CROs. With a Bachelor of Industrial Pharmacy from the University of the Philippines and a Pharmacist license, Jennifer’s research operations experience includes monitoring, auditing, project leadership, feasibility, study start-up, driving inspection readiness and hosting regulatory inspection, client engagement and business development, learning & development and organization SOP development/review. Jennifer has contributed to the transformation of the Philippine clinical research industry – bringing improvement to the local clinical research regulations and practices and is the founding President of a non-profit organization, the Philippine Clinical Research Professionals Inc, with more than 400 members from pharmaceutical and CROs and has. More recently, volunteered pro-bono services during the Covid-19 pandemic to provide trial management consultancy to the Philippine DOH-funded trials such as WHO Solidarity COVID-19 Treatment and Vaccine trials, Avigan COVID-19 treatment trial, and Philippine Heart Association funded cardiovascular outcome study. </p> </div>  </div>  <div class="row speaker-row align-items-top"> <div class="col-lg-3 col-sm-4 mb-lg-0 mb-4"> <img class="card-img rounded-circle" src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/panelists/BabajiYadav.jpg" alt="Babaji Yadav" /> </div>  <div class="col-lg-9 col-sm-8 speaker-info"> <h3>Babaji Yadav</h3> <h5>Senior Consultant, Novotech Drug Development Consulting</h5> <p>Babaji Yadav is a Senior Consultant with over eight years of academic experience in pre-clinical oncology drug development and eight years of industry experience in drug development. Babaji has a strong background in pharmaceutical sciences with a Ph.D. in Pharmacology and Toxicology from the University of Otago, New Zealand. Previously he has worked as a Research Project Manager to oversee IND-enabling toxicology studies for lead oncology drugs and, prior to joining Novotech, was a Clinical Project Manager for early-phase oncology trials. Babaji is a UK Registered Toxicologist and at Novotech he is focused on providing technical toxicology advice and product development strategies to facilitate the entry of client’s compounds into clinical trials. Babaji has experience in small molecules, combination products, and biologicals including vaccines, proteins, monoclonal antibodies, and advanced cell and gene therapies.</p> </div>  </div>  <div class="row speaker-row align-items-center"> <div class="col-lg-3 col-sm-4 mb-lg-0 mb-4"> <img class="card-img rounded-circle" src="/assets/images/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/panelists/KariAbitbol.jpg" alt="Kari Abitbol" /> </div>  <div class="col-lg-9 col-sm-8 speaker-info"> <h6>moderator</h6> <h3>Kari Abitbol</h3> <h5>Director, Client Success, Endpoints News</h5> <p>As head of the client success team at Endpoints News, Kari oversees campaign delivery for all advertising and client-directed webinars. </p> </div>  </div>  </div> </section> <div class="modal" role="dialog" id="registration_success" aria-hidden="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="modal-header align-items-center"> <svg version="1.1" width="280px" class="d-inline-block align-top ew-logo" alt="Endpoints Webinars" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewbox="0 0 280 46" style="enable-background:new 0 0 280 46;" xml:space="preserve"> <path class="ew-logo-primary" d="M84.3,0.2l-7.7,24.1h-0.5l-8-24.1h-7.8l-7.3,24.1h-0.5L44.3,0.2h-4h-8.8H0V46h39l-3.9-10.2h-24v-8.1h20.6 L28.1,18h-17v-7.6h24.3L48.7,46h7.7l8-25.6h0.4L72.2,46h7.7L97.1,0.2H84.3z"/> <path class="ew-logo-secondary" d="M122.2,33.3l-4.5,12.5h-1l-7-17.7l2.5-0.5l4.9,12.8h0.2l4.5-12.8h0.6l4.7,12.8h0.2l4.8-12.8l2.5,0.5l-7,17.7h-1 L122.2,33.3C122.4,33.3,122.2,33.3,122.2,33.3z M151.2,30.1H142v5.3h8.1v2.3H142v5.7h9.5v2.3h-12.1V27.8h11.7L151.2,30.1L151.2,30.1 z M166.8,36.5c2.2,0.4,3.7,2.1,3.7,4.2c0,3.1-2.4,4.9-6.3,4.9h-6.4V27.8h5.9c4.2,0,5.8,2.4,5.8,4.7c0,1.6-0.8,3.1-2.6,3.8V36.5 L166.8,36.5z M163.7,30.1h-3.5v5.3h3.6c1.9,0,2.9-0.9,2.9-2.7C166.7,30.7,165.3,30.1,163.7,30.1z M160.2,37.7v5.7h4.2 c1.9,0,3.4-0.9,3.4-2.8s-1.6-2.9-3.6-2.9L160.2,37.7L160.2,37.7z M179.1,45.6h-2.5V27.8h2.5V45.6z M199.9,40.7l0.3-0.1V27.8h2.5 v17.8l-1,0.3l-12.3-13l-0.3,0.1v12.7h-2.5V27.9l1-0.3L199.9,40.7z M220.1,41.5h-8.2l-1.9,4.3l-2.6-0.4l8.3-17.8h0.5l8.4,17.8 l-2.6,0.4L220.1,41.5z M212.9,39.2h6.1l-3-6.6h-0.1L212.9,39.2z M243.5,45v0.4l-2.4,0.5l-6.3-7.2h-2.9v7h-2.5V27.8h6.5 c3.7,0,6.1,2.2,6.1,5.3c0,2.7-1.6,4.7-4.4,5.2L243.5,45z M235.8,30.1h-3.8v6.3h3.8c2.3,0,3.7-1.1,3.7-3.3 C239.5,31.1,237.9,30.1,235.8,30.1z M248.5,41.7c1.5,1.2,3.2,1.9,5.6,1.9c3.1,0,4.2-1.3,4.2-2.7c0-1.6-1.5-2.3-4.5-3.6 c-4.1-1.8-5.5-2.9-5.5-5.2s2.1-4.7,6.1-4.7c2.7,0,4.9,0.9,6,1.9l-0.9,2.1c-1.5-1.1-3.2-1.6-5.1-1.6c-2.3,0-3.7,1-3.7,2.2 c0,1.3,1.1,1.9,4.7,3.4c4.1,1.6,5.4,3.3,5.4,5.7c0,3-2.6,4.9-6.9,4.9c-2.9,0-5.5-1.1-6.5-2.1L248.5,41.7z M122.8,4.6h-8.1v3h7.1v3.8 h-7.1v3.2h8.4v4H110V0.6h12.8L122.8,4.6L122.8,4.6z M141.2,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L141.2,10.9z M151.7,18.7V0.6h6.4c5.4,0,9.5,3.7,9.5,9.1c0,5.8-4,9.1-9.5,9.1C158.1,18.7,151.7,18.7,151.7,18.7z M158.4,14.7 c2.6,0,4.4-1.8,4.4-5.1c0-3.1-2.5-4.9-4.5-4.9h-2.1v10.1C156.2,14.7,158.4,14.7,158.4,14.7z M178.9,12.5H177v6.2h-4.7V0.6h6.7 c4.1,0,7,2.4,7,6.3C186,9.3,184.3,12.5,178.9,12.5z M178.5,4.4H177v4.5h1.6c1.5,0,2.5-0.7,2.5-2.1C181.1,5.5,180,4.4,178.5,4.4z M199.3,19.1c-5.7,0-9.7-4.1-9.7-9.3c0-5.8,4.7-9.5,9.7-9.5c4.9,0,9.7,3.7,9.7,9.5C208.9,14.9,205.1,19.1,199.3,19.1z M199.2,4.4 c-2.5,0-4.9,1.9-4.9,5.3c0,2.7,1.6,5.3,4.9,5.3c2.7,0,4.9-2,4.9-5.3C204.1,6.5,201.9,4.4,199.2,4.4z M218.6,18.7h-4.7V0.6h4.7V18.7z M237.3,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L237.3,10.9z M257,4.6v14.1h-4.7V4.6h-5.5v-4h15.6v4H257L257,4.6z M267.1,13.2c1.6,1,3.7,1.9,5.8,1.9c1.6,0,2.4-0.7,2.4-1.5c0-1.1-1.2-1.5-3.5-2.6c-3.7-1.7-5.2-3-5.2-5.7s2.2-5.2,6.7-5.2 c2.6,0,4.8,0.6,6.4,1.7l-1.2,3.8c-1.8-1-3.6-1.6-5.3-1.6c-1.4,0-2,0.5-2,1.3s0.7,1.2,3.6,2.5c3.9,1.8,5.3,3.5,5.3,5.9 c0,3.4-3.1,5.2-7.4,5.2c-3.1,0-5.8-1.1-6.9-2.1L267.1,13.2z"/> </svg> <button class="ui_form_close" data-dismiss="modal">close</button> </div> <div class="modal-body"> <div class="row"> <div class="col-12 modal-container"> <h1>Your seat is reserved!</h1> <h2>Keeping pace with the evolving global landscape in vaccine development </h2> <div class="time"> 11:00 am - 12:00 pm EST </div> <div class="time local-time">LOCAL TIME</div> <p>A confirmation email with information on how to join the webinar has been sent to you.</p> <p>Before joining, be sure to check <a href="https://support.zoom.us/hc/en-us/articles/201362023-System-requirements-for-Windows-macOS-and-Linux" target="_blank" rel="noopener nofollow">system requirements</a> to avoid any connection issues. </p> </div> </div> </div> </div> </div> </div> <div class="modal" role="dialog" id="registration_declined" aria-hidden="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="modal-header align-items-center"> <svg version="1.1" width="280px" class="d-inline-block align-top ew-logo" alt="Endpoints Webinars" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewbox="0 0 280 46" style="enable-background:new 0 0 280 46;" xml:space="preserve"> <path class="ew-logo-primary" d="M84.3,0.2l-7.7,24.1h-0.5l-8-24.1h-7.8l-7.3,24.1h-0.5L44.3,0.2h-4h-8.8H0V46h39l-3.9-10.2h-24v-8.1h20.6 L28.1,18h-17v-7.6h24.3L48.7,46h7.7l8-25.6h0.4L72.2,46h7.7L97.1,0.2H84.3z"/> <path class="ew-logo-secondary" d="M122.2,33.3l-4.5,12.5h-1l-7-17.7l2.5-0.5l4.9,12.8h0.2l4.5-12.8h0.6l4.7,12.8h0.2l4.8-12.8l2.5,0.5l-7,17.7h-1 L122.2,33.3C122.4,33.3,122.2,33.3,122.2,33.3z M151.2,30.1H142v5.3h8.1v2.3H142v5.7h9.5v2.3h-12.1V27.8h11.7L151.2,30.1L151.2,30.1 z M166.8,36.5c2.2,0.4,3.7,2.1,3.7,4.2c0,3.1-2.4,4.9-6.3,4.9h-6.4V27.8h5.9c4.2,0,5.8,2.4,5.8,4.7c0,1.6-0.8,3.1-2.6,3.8V36.5 L166.8,36.5z M163.7,30.1h-3.5v5.3h3.6c1.9,0,2.9-0.9,2.9-2.7C166.7,30.7,165.3,30.1,163.7,30.1z M160.2,37.7v5.7h4.2 c1.9,0,3.4-0.9,3.4-2.8s-1.6-2.9-3.6-2.9L160.2,37.7L160.2,37.7z M179.1,45.6h-2.5V27.8h2.5V45.6z M199.9,40.7l0.3-0.1V27.8h2.5 v17.8l-1,0.3l-12.3-13l-0.3,0.1v12.7h-2.5V27.9l1-0.3L199.9,40.7z M220.1,41.5h-8.2l-1.9,4.3l-2.6-0.4l8.3-17.8h0.5l8.4,17.8 l-2.6,0.4L220.1,41.5z M212.9,39.2h6.1l-3-6.6h-0.1L212.9,39.2z M243.5,45v0.4l-2.4,0.5l-6.3-7.2h-2.9v7h-2.5V27.8h6.5 c3.7,0,6.1,2.2,6.1,5.3c0,2.7-1.6,4.7-4.4,5.2L243.5,45z M235.8,30.1h-3.8v6.3h3.8c2.3,0,3.7-1.1,3.7-3.3 C239.5,31.1,237.9,30.1,235.8,30.1z M248.5,41.7c1.5,1.2,3.2,1.9,5.6,1.9c3.1,0,4.2-1.3,4.2-2.7c0-1.6-1.5-2.3-4.5-3.6 c-4.1-1.8-5.5-2.9-5.5-5.2s2.1-4.7,6.1-4.7c2.7,0,4.9,0.9,6,1.9l-0.9,2.1c-1.5-1.1-3.2-1.6-5.1-1.6c-2.3,0-3.7,1-3.7,2.2 c0,1.3,1.1,1.9,4.7,3.4c4.1,1.6,5.4,3.3,5.4,5.7c0,3-2.6,4.9-6.9,4.9c-2.9,0-5.5-1.1-6.5-2.1L248.5,41.7z M122.8,4.6h-8.1v3h7.1v3.8 h-7.1v3.2h8.4v4H110V0.6h12.8L122.8,4.6L122.8,4.6z M141.2,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L141.2,10.9z M151.7,18.7V0.6h6.4c5.4,0,9.5,3.7,9.5,9.1c0,5.8-4,9.1-9.5,9.1C158.1,18.7,151.7,18.7,151.7,18.7z M158.4,14.7 c2.6,0,4.4-1.8,4.4-5.1c0-3.1-2.5-4.9-4.5-4.9h-2.1v10.1C156.2,14.7,158.4,14.7,158.4,14.7z M178.9,12.5H177v6.2h-4.7V0.6h6.7 c4.1,0,7,2.4,7,6.3C186,9.3,184.3,12.5,178.9,12.5z M178.5,4.4H177v4.5h1.6c1.5,0,2.5-0.7,2.5-2.1C181.1,5.5,180,4.4,178.5,4.4z M199.3,19.1c-5.7,0-9.7-4.1-9.7-9.3c0-5.8,4.7-9.5,9.7-9.5c4.9,0,9.7,3.7,9.7,9.5C208.9,14.9,205.1,19.1,199.3,19.1z M199.2,4.4 c-2.5,0-4.9,1.9-4.9,5.3c0,2.7,1.6,5.3,4.9,5.3c2.7,0,4.9-2,4.9-5.3C204.1,6.5,201.9,4.4,199.2,4.4z M218.6,18.7h-4.7V0.6h4.7V18.7z M237.3,10.9h0.2V0.6h4.7v18.1h-3l-9.7-10.3h-0.2v10.3h-4.7V0.6h3L237.3,10.9z M257,4.6v14.1h-4.7V4.6h-5.5v-4h15.6v4H257L257,4.6z M267.1,13.2c1.6,1,3.7,1.9,5.8,1.9c1.6,0,2.4-0.7,2.4-1.5c0-1.1-1.2-1.5-3.5-2.6c-3.7-1.7-5.2-3-5.2-5.7s2.2-5.2,6.7-5.2 c2.6,0,4.8,0.6,6.4,1.7l-1.2,3.8c-1.8-1-3.6-1.6-5.3-1.6c-1.4,0-2,0.5-2,1.3s0.7,1.2,3.6,2.5c3.9,1.8,5.3,3.5,5.3,5.9 c0,3.4-3.1,5.2-7.4,5.2c-3.1,0-5.8-1.1-6.9-2.1L267.1,13.2z"/> </svg> <button class="ui_form_close" data-dismiss="modal">close</button> </div> <div class="modal-body"> <div class="row"> <div class="col-12 modal-container"> <h1>Registration declined</h1> <h2>Keeping pace with the evolving global landscape in vaccine development </h2> <p class="mt-3">Apologies, the sponsor for this webinar has opted to block certain domains.</p> <p>Please feel free to check out our other upcoming webinars at <a href="https://webinars.endpts.com/">https://webinars.endpts.com/</a></p> </div> </div> </div> </div> </div> </div> <script src="https://webinars.endpts.com/assets/js/jquery-3.4.1.min.js" type="text/javascript"></script> <script src="https://webinars.endpts.com/assets/js/bootstrap.bundle.min.js" type="text/javascript"></script> <script src="https://webinars.endpts.com/assets/js/main.js?v=1.0.17" type="text/javascript"></script><script type='text/javascript'>/* <![CDATA[ */var webinar = {"id":81312372321,"title":"Keeping pace with the evolving global landscape in vaccine development ","start":1678377600,"end":1678381200,"fields":{"email":{"name":"email","required":true},"first_name":{"name":"first_name","required":true},"last_name":{"name":"last_name","required":true},"country":{"name":"country","required":true,"answers":{"AF":"Afghanistan","AX":"\u00c5land Islands","AL":"Albania","DZ":"Algeria","AS":"American Samoa","AD":"Andorra","AO":"Angola","AI":"Anguilla","AQ":"Antarctica","AG":"Antigua and Barbuda","AR":"Argentina","AM":"Armenia","AW":"Aruba","AU":"Australia","AT":"Austria","AZ":"Azerbaijan","BS":"Bahamas","BH":"Bahrain","BD":"Bangladesh","BB":"Barbados","BY":"Belarus","BE":"Belgium","BZ":"Belize","BJ":"Benin","BM":"Bermuda","BT":"Bhutan","BO":"Bolivia","BQ":"Bonaire, Sint Eustatius and Saba","BA":"Bosnia and Herzegovina","BW":"Botswana","BV":"Bouvet Island","BR":"Brazil","IO":"British Indian Ocean Territory","BN":"Brunei Darussalam","BG":"Bulgaria","BF":"Burkina Faso","BI":"Burundi","CV":"Cabo Verde","KH":"Cambodia","CM":"Cameroon","CA":"Canada","KY":"Cayman Islands","CF":"Central African Republic","TD":"Chad","CL":"Chile","CN":"China","CX":"Christmas Island","CC":"Cocos (Keeling) Islands","CO":"Colombia","KM":"Comoros","CG":"Congo","CD":"Congo","CK":"Cook Islands","CR":"Costa Rica","CI":"C\u00f4te d'Ivoire","HR":"Croatia","CW":"Cura\u00e7ao","CY":"Cyprus","CZ":"Czechia","DK":"Denmark","DJ":"Djibouti","DM":"Dominica","DO":"Dominican Republic","EC":"Ecuador","EG":"Egypt","SV":"El Salvador","GQ":"Equatorial Guinea","ER":"Eritrea","EE":"Estonia","SZ":"Eswatini","ET":"Ethiopia","FK":"Falkland Islands (Malvinas)","FO":"Faroe Islands","FJ":"Fiji","FI":"Finland","FR":"France","GF":"French Guiana","PF":"French Polynesia","TF":"French Southern Territories","GA":"Gabon","GM":"Gambia","GE":"Georgia","DE":"Germany","GH":"Ghana","GI":"Gibraltar","GR":"Greece","GL":"Greenland","GD":"Grenada","GP":"Guadeloupe","GU":"Guam","GT":"Guatemala","GG":"Guernsey","GN":"Guinea","GW":"Guinea-Bissau","GY":"Guyana","HT":"Haiti","HM":"Heard Island and McDonald Islands","VA":"Holy See","HN":"Honduras","HK":"Hong Kong SAR","HU":"Hungary","IS":"Iceland","IN":"India","ID":"Indonesia","IQ":"Iraq","IE":"Ireland","IM":"Isle of Man","IL":"Israel","IT":"Italy","JM":"Jamaica","JP":"Japan","JE":"Jersey","JO":"Jordan","KZ":"Kazakhstan","KE":"Kenya","KI":"Kiribati","KR":"Korea","KW":"Kuwait","KG":"Kyrgyzstan","LA":"Lao People's Democratic Republic","LV":"Latvia","LB":"Lebanon","LS":"Lesotho","LR":"Liberia","LY":"Libya","LI":"Liechtenstein","LT":"Lithuania","LU":"Luxembourg","MO":"Macau SAR","MG":"Madagascar","MW":"Malawi","MY":"Malaysia","MV":"Maldives","ML":"Mali","MT":"Malta","MH":"Marshall Islands","MQ":"Martinique","MR":"Mauritania","MU":"Mauritius","YT":"Mayotte","MX":"Mexico","FM":"Micronesia","MD":"Moldova","MC":"Monaco","MN":"Mongolia","ME":"Montenegro","MS":"Montserrat","MA":"Morocco","MZ":"Mozambique","MM":"Myanmar","NA":"Namibia","NR":"Nauru","NP":"Nepal","NL":"Netherlands","NC":"New Caledonia","NZ":"New Zealand","NI":"Nicaragua","NE":"Niger","NG":"Nigeria","NU":"Niue","NF":"Norfolk Island","MP":"Northern Mariana Islands","MK":"North Macedonia","NO":"Norway","OM":"Oman","PK":"Pakistan","PW":"Palau","PS":"Palestine","PA":"Panama","PG":"Papua New Guinea","PY":"Paraguay","PE":"Peru","PH":"Philippines","PN":"Pitcairn","PL":"Poland","PT":"Portugal","PR":"Puerto Rico","QA":"Qatar","RE":"R\u00e9union","RO":"Romania","RU":"Russian Federation","RW":"Rwanda","BL":"Saint Barth\u00e9lemy","SH":"Saint Helena, Ascension and Tristan da Cunha","KN":"Saint Kitts and Nevis","LC":"Saint Lucia","MF":"Saint Martin (French part)","PM":"Saint Pierre and Miquelon","VC":"Saint Vincent and the Grenadines","WS":"Samoa","SM":"San Marino","ST":"Sao Tome and Principe","SA":"Saudi Arabia","SN":"Senegal","RS":"Serbia","SC":"Seychelles","SL":"Sierra Leone","SG":"Singapore","SX":"Sint Maarten (Dutch part)","SK":"Slovakia","SI":"Slovenia","SB":"Solomon Islands","SO":"Somalia","ZA":"South Africa","GS":"South Georgia and the South Sandwich Islands","SS":"South Sudan","ES":"Spain","LK":"Sri Lanka","SR":"Suriname","SJ":"Svalbard and Jan Mayen","SE":"Sweden","CH":"Switzerland","TW":"Taiwan","TJ":"Tajikistan","TZ":"Tanzania","TH":"Thailand","TL":"Timor-Leste","TG":"Togo","TK":"Tokelau","TO":"Tonga","TT":"Trinidad and Tobago","TN":"Tunisia","TR":"Turkey","TM":"Turkmenistan","TC":"Turks and Caicos Islands","TV":"Tuvalu","UG":"Uganda","UA":"Ukraine","AE":"United Arab Emirates","GB":"United Kingdom","UM":"United States Minor Outlying Islands","US":"United States of America","UY":"Uruguay","UZ":"Uzbekistan","VU":"Vanuatu","VE":"Venezuela","VN":"Viet Nam","VG":"Virgin Islands (British)","VI":"Virgin Islands (U.S.)","WF":"Wallis and Futuna","EH":"Western Sahara","YE":"Yemen","ZM":"Zambia","ZW":"Zimbabwe","Other":"Other"}},"org":{"name":"org","required":true},"job_title":{"name":"job_title","required":true}},"vimeo_link":"https:\/\/vimeo.com\/806365419\/1c3cd466ad"};/* ]]> */</script><script>!function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '174990157837477'); fbq('track', 'PageView'); _linkedin_partner_id = "2273916"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); (function(){var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(); (function(w,d,t,r,u){var f,n,i;w[u]=w[u]||[],f=function(){var o={ti:"56366962"};o.q=w[u],w[u]=new UET(o),w[u].push("pageLoad")},n=d.createElement(t),n.src=r,n.async=1,n.onload=n.onreadystatechange=function(){var s=this.readyState;s&&s!=="loaded"&&s!=="complete"||(f(),n.onload=n.onreadystatechange=null)},i=d.getElementsByTagName(t)[0],i.parentNode.insertBefore(n,i)})(window,document,"script","//bat.bing.com/bat.js","uetq"); </script> </body> </html>

CINXE.COM

Keeping pace with the evolving global landscape in vaccine development - Endpoints Webinars